Literature DB >> 10732688

Computerized classification of corpus cavernosum electromyogram signals by the use of discriminant analysis and artificial neural networks to support diagnosis of erectile dysfunction.

B Kellner1, C G Stief, H Hinrichs, C Hartung.   

Abstract

Corpus cavernosum electromyogram (CC-EMG) provides diagnostic information on cavernous autonomic innervation and a measure of the degree to which the cavernous smooth muscle cells are intact. The complicated CC-EMG is evaluated and used in the diagnosis of patients suffering from erectile dysfunction. The evaluation procedure has been simplified by applying digital signal processing techniques. Since mathematically-based interpretations require quantitative data, spectral analysis was performed. The derived biosignals were analyzed by fast Fourier transform (FFT). Besides various other spectral parameters, specific frequency bands were determined in the power spectrum using factor analysis. The parameters were used for the computerized classification of normal and pathological CC-EMG data and the classification was performed using two independent methods: discriminant analysis (DA) and artificial neural networks (ANN). A medical expert analyzed a total of 200 CC-EMG recordings from patients with and without erectile dysfunction and separated these into normal (136) and pathological (64) cases. Although each independent method had already resulted in a relatively high number of correct classifications, the classification success rate could be slightly improved by using a combination of both classification methods. A total of 72.79% and 77.94% were successfully classified using DA and ANN, respectively. The combination of both methods increased the classification success to 80.15%. The results of this study enabled impartial evaluation of the CC-EMG signals for clinical diagnostic purposes of erectile dysfunction. This method provided an objective and easy way to analyze the CC-EMG. Furthermore, this results in patient diagnosis becoming an easier task for less experienced doctors, since little knowledge of the raw signal is needed.

Entities:  

Mesh:

Year:  2000        PMID: 10732688     DOI: 10.1007/s002400050002

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  6 in total

1.  Classification of EMG signals using neuro-fuzzy system and diagnosis of neuromuscular diseases.

Authors:  Sabri Koçer
Journal:  J Med Syst       Date:  2010-06       Impact factor: 4.460

Review 2.  Neurogenic erectile dysfunction.

Authors:  T F Lue
Journal:  Clin Auton Res       Date:  2001-10       Impact factor: 4.435

Review 3.  Applications of artificial intelligence in the diagnosis and prediction of erectile dysfunction: a narrative review.

Authors:  Yang Xiong; Yangchang Zhang; Fuxun Zhang; Changjing Wu; Feng Qin; Jiuhong Yuan
Journal:  Int J Impot Res       Date:  2022-01-13       Impact factor: 2.408

Review 4.  Cardiovascular/Stroke Risk Assessment in Patients with Erectile Dysfunction-A Role of Carotid Wall Arterial Imaging and Plaque Tissue Characterization Using Artificial Intelligence Paradigm: A Narrative Review.

Authors:  Narendra N Khanna; Mahesh Maindarkar; Ajit Saxena; Puneet Ahluwalia; Sudip Paul; Saurabh K Srivastava; Elisa Cuadrado-Godia; Aditya Sharma; Tomaz Omerzu; Luca Saba; Sophie Mavrogeni; Monika Turk; John R Laird; George D Kitas; Mostafa Fatemi; Al Baha Barqawi; Martin Miner; Inder M Singh; Amer Johri; Mannudeep M Kalra; Vikas Agarwal; Kosmas I Paraskevas; Jagjit S Teji; Mostafa M Fouda; Gyan Pareek; Jasjit S Suri
Journal:  Diagnostics (Basel)       Date:  2022-05-17

5.  The hypoactive corpora cavernosa with degenerative erectile dysfunction: a new syndrome.

Authors:  Ahmed Shafik; Ismail Ahmed; Olfat El Sibai; Ali A Shafik
Journal:  BMC Urol       Date:  2006-05-24       Impact factor: 2.264

6.  Study of the response of the penile corporal tissue and cavernosus muscles to micturition.

Authors:  Ahmed Shafik; Ismail A Shafik; Olfat El Sibai; Ali A Shafik
Journal:  BMC Urol       Date:  2008-03-02       Impact factor: 2.264

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.